REGEN BIOPHARMA, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
REGEN BIOPHARMA, INC. (RGBP) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$5.18 million as of 2024-03-31, per its 10-Q filed 2024-04-24.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-04-24
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$5.18M.
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$5.24M.
- 2023-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$5.10M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$5.03M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2024-03-31 | -$5.18M 10-Q · filed 2024-04-24 | |
| 2023-12-31 | -$5.24M 10-Q · filed 2024-01-19 | |
| 2023-09-30 | -$5.10M 10-Q · filed 2024-04-24 | |
| 2023-06-30 | -$5.03M 10-Q · filed 2023-07-25 | |
| 2023-03-31 | -$4.93M 10-Q · filed 2023-04-18 | |
| 2022-12-31 | -$4.88M 10-Q · filed 2023-01-19 | |
| 2022-09-30 | -$8.04M 10-K · filed 2023-11-20 | |
| 2022-06-30 | -$8.35M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | -$76.75M 10-Q · filed 2022-04-21 | |
| 2021-12-31 | -$9.76M 10-Q · filed 2022-04-21 | |
| 2021-09-30 | -$13.49M 10-K · filed 2022-11-15 | |
| 2021-06-30 | -$10.54M 10-Q/A · filed 2021-12-22 | |
| 2021-03-31 | -$5.07M 10-Q · filed 2022-04-21 | -$5.07M 10-Q · filed 2021-08-18 |
| 2020-12-31 | -$5.58M 10-Q · filed 2022-04-21 | |
| 2020-09-30 | -$7.33M 10-Q · filed 2022-04-21 | |
| 2020-06-30 | -$8.56M 10-Q/A · filed 2021-12-22 | -$8.56M 10-Q · filed 2021-08-05 |
| 2020-03-31 | -$11.77M 10-Q/A · filed 2021-12-22 | |
| 2019-12-31 | -$7.70M 10-Q/A · filed 2021-12-22 | |
| 2019-09-30 | -$10.91M 10-Q/A · filed 2021-12-22 | |
| 2019-06-30 | -$12.79M 10-Q · filed 2019-10-24 | |
| 2019-03-31 | -$8.81M 10-Q · filed 2019-10-24 | -$8.83M 10-Q · filed 2019-08-29 |
| 2018-12-31 | -$8.66M 10-Q · filed 2019-10-24 | |
| 2018-09-30 | -$9.12M 10-K · filed 2021-06-21 | |
| 2018-06-30 | -$8.57M 10-Q · filed 2019-10-24 | |
| 2018-03-31 | -$8.55M 10-Q · filed 2019-10-24 | |
| 2017-12-31 | -$7.80M 10-Q · filed 2019-10-24 | |
| 2017-09-30 | -$5.25M 10-Q · filed 2019-10-24 |